| Mepolizumab effectiveness and identification of super-responders in severe asthma ES Harvey, D Langton, C Katelaris, S Stevens, CS Farah, A Gillman, ... European Respiratory Journal 55 (5), 2020 | 178 | 2020 |
| Mepolizumab and oral corticosteroid stewardship: data from the Australian Mepolizumab Registry D Thomas, ES Harvey, VM McDonald, S Stevens, JW Upham, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (7), 2715-2724. e5, 2021 | 21 | 2021 |
| Mepolizumab improves clinical outcomes in severe eosinophilic asthma despite comorbidities V Kritikos, E Harvey, C Farah, A Gillman, M Hew, C Katelaris, D Langton, ... RESPIROLOGY 27, 100-101, 2022 | | 2022 |
| ORAL CORTICOSTEROID EXPOSURE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA: DATA FROM THE AUSTRALIAN MEPOLIZUMAB REGISTRY D Thomas, E Harvey, S Stevens, V McDonald, J Simpson, J Upham, ... RESPIROLOGY 25, 124-124, 2020 | | 2020 |
| MEPOLIZUMAB REDUCES EXACERBATIONS IN SEVERE EOSINOPHILIC ASTHMA: A REAL-WORLD STUDY. E Harvey, D Langton, C Farah, A Gillman, J Harrington, M Hew, ... RESPIROLOGY 25, 105-105, 2020 | | 2020 |
